sr141716 has been researched along with heroin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Di Chiara, G; Pontieri, FE; Tanda, G | 1 |
| Broadbear, J; Butelman, ER; Kishioka, S; Lee, KO; Vivian, JA; Woods, JH | 1 |
| Braida, D; Parolaro, D; Pozzi, M; Sala, M | 1 |
| Carrera, MR; Chowen, JA; Cossu, G; del Arco, I; Fattore, L; Fratta, W; Gomez, R; Koob, GF; Maldonado, R; Navarro, M; Rodriguez de Fonseca, F; Valverde, O; Villanua, MA | 1 |
| Braida, D; Cavallini, R; Pozzi, M; Sala, M | 1 |
| Antoniou, K; Goldberg, SR; Panlilio, LV; Pappas, LA; Solinas, M | 1 |
| Caillé, S; Parsons, LH | 1 |
| Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Spano, MS | 1 |
| Carrera, MR; Del Arco, I; Koob, GF; Navarro, M; Rodríguez de Fonseca, F; Trigo, JM | 1 |
| Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Spano, S | 1 |
| Ellgren, M; Hurd, YL; Spano, SM | 1 |
| Alvarez-Jaimes, L; Parsons, LH; Polis, I | 1 |
| Fadda, P; Fattore, L; Fratta, W; Melis, V; Spano, M | 1 |
| Ding, H; Kiguchi, N; Kishioka, S; Ko, MC; Mabry, KM | 1 |
14 other study(ies) available for sr141716 and heroin
| Article | Year |
|---|---|
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Topics: Animals; Benzoxazines; Dopamine; Dronabinol; Heroin; Male; Microdialysis; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant | 1997 |
Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
Topics: Analgesics, Opioid; Animals; Benzeneacetamides; Benzoxazines; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Heart Rate; Heroin; Macaca mulatta; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Pyrrolidines; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Respiratory Mechanics; Rimonabant | 1998 |
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzimidazoles; Conditioning, Operant; Cyclohexanols; Heroin; Male; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration | 2001 |
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Topics: Animals; Avoidance Learning; Cannabinoids; Caudate Nucleus; Conditioning, Operant; Disease Models, Animal; Heroin; Heroin Dependence; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Putamen; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; RNA, Messenger; Self Administration; Septum of Brain | 2001 |
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Brain; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Heroin; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reward; Rimonabant | 2001 |
The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio
Topics: Analgesics, Opioid; Animals; Dronabinol; Drug Interactions; Hallucinogens; Heroin; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration; Sodium Chloride | 2003 |
SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats.
Topics: Animals; Area Under Curve; Behavior, Animal; Bradykinin; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Heroin; Male; Microdialysis; Narcotics; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement Schedule; Rimonabant; Self Administration; Time Factors | 2003 |
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Topics: Animals; Behavior, Animal; Benzoxazines; Cannabinoids; Cocaine; Extinction, Psychological; Heroin; Male; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Time Factors | 2004 |
Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.
Topics: Animals; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Heroin; Heroin Dependence; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Rimonabant; Self Administration | 2004 |
Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Topics: Animals; Behavior, Addictive; Benzoxazines; Conditioning, Operant; Cyclohexanols; Drug Interactions; Extinction, Psychological; Heroin; Heroin Dependence; Male; Morpholines; Naloxone; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration | 2005 |
Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Animals; Animals, Newborn; Benzoxazines; Dose-Response Relationship, Drug; Dronabinol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Gene Expression Regulation; Guanosine 5'-O-(3-Thiotriphosphate); Heroin; In Situ Hybridization; Limbic System; Male; Morpholines; Naphthalenes; Neurons; Piperidines; Protein Precursors; Pyrazoles; Radioligand Assay; Rats; Rats, Long-Evans; Reinforcement, Psychology; Rimonabant; Self Administration; Sulfur Isotopes; Tritium | 2007 |
Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
Topics: Amygdala; Animals; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Heroin; Heroin Dependence; Male; Motivation; Narcotics; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Reward; Rimonabant | 2008 |
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Cannabinoids; Drug Substitution; Drug Synergism; Heroin; Male; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Rimonabant; Self Administration | 2011 |
Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates.
Topics: Analgesics, Opioid; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Female; Heroin; Male; Morphine; Naltrexone; Rimonabant | 2023 |